Aquestive Therapeutics Inc

NASDAQ:AQST   1:46:34 PM EDT
4.92
+0.25 (+5.35%)
Other Pre-Announcement

Aquestive Therapeutics Reports Quarterly Net Loss Per Share Basic And Diluted Of $0.60

Published: 03/09/2021 22:42 GMT
Aquestive Therapeutics Inc (AQST) - Aquestive Therapeutics Inc - Qtrly Net Loss per Share Basic and Diluted $0.60.
Aquestive Therapeutics Inc - Sees 2021 Total Revenues of Approximately $38 Million to $42 Million.
Aquestive Therapeutics Inc - Sees 2021 Non-GAAP Adjusted EBITDA Loss of Approximately $42 Million to $45 Million.
Aquestive Therapeutics Inc - Total Revenues Were $7.1 Million in the Fourth Quarter 2020, Compared to $16.4 Million in the Fourth Quarter 2019.